Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis

Percutaneous aortic valve replacement is a new less‐invasive alternative for high‐risk surgical candidates with aortic stenosis. However, the clinical experience is still limited, and the currently available ‘first‐generation devices’ revealed technical shortcomings, such as lack of repositionability and presence of paravalvular leakages. We report the first‐in‐man experience with the new self‐expanding Lotus™ Valve prosthesis composed of a nitinol frame with implemented bovine pericardial leaflets which is designed to address these issues, being repositionable and covered by a flexible membrane to seal paravalvular gaps. We implanted this prosthesis in a 93‐year old patient presenting with severe symptomatic aortic stenosis (valve area: 0.6 cm2). Surgical valve replacement had been declined due to comorbidities.

[1]  M. Leon,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis First Human Case Description , 2002 .

[2]  Philippe Ravaud,et al.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.

[3]  Christopher E. Buller,et al.  Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.

[4]  B. Carabello.  Clinical practice. Aortic stenosis. , 2002, The New England journal of medicine.

[5]  W. Likoff,et al.  Valvular Heart Disease , 2018, The Perioperative Medicine Consult Handbook.

[6]  D. Lindblom,et al.  Long-term relative survival rates after heart valve replacement. , 1990, Journal of the American College of Cardiology.

[7]  M. Cotrufo,et al.  Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience , 2003, Heart.

[8]  Alain Cribier,et al.  Acute Improvement in Global and Regional Left Ventricular Systolic Function After Percutaneous Heart Valve Implantation in Patients With Symptomatic Aortic Stenosis , 2004, Circulation.

[9]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[10]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[11]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006 .

[12]  B. Heilbron,et al.  The natural history and rate of progression of aortic stenosis. , 1998, Chest.

[13]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[14]  Anson Cheung,et al.  Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience , 2006, Circulation.

[15]  P. Kolh,et al.  Aortic valve replacement in the octogenarians: perioperative outcome and clinical follow-up. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  B. Astor,et al.  Mortality after aortic valve replacement: results from a nationally representative database. , 2000, The Annals of thoracic surgery.

[17]  Thomas Felderhoff,et al.  Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study , 2006, Circulation.

[18]  Franz Schwarz,et al.  The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.

[19]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[20]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[21]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[22]  Colin Berry,et al.  Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving™ System , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  P. Wenaweser,et al.  Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving system , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  Thomas Felderhoff,et al.  First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  P. Théroux,et al.  Prognostic significance of newly acquired bundle branch block after aortic valve replacement. , 2004, The American journal of cardiology.